Alternative strategies for controlling imaging utilization, radiology benefit managers and computerized decision support, squared off in a scientific session Sunday.
Alternative strategies for controlling imaging utilization, radiology benefit managers and computerized decision support, squared off in a scientific session Sunday.
Advocates of computerized clinical decision support said their strategies are emerging as a more clinician-friendly alternative to controlling inappropriate imaging utilization. A representative from one radiology benefit management company said data supporting the computer-based approach benefits from progress already made by the RBMs, and it remains to be seen whether new strategies for controlling imaging utilization will be all that successful.
RBMs emerged earlier in this decade as the front-line strategy by commercial insurers for controlling inappropriate imaging utilization. Using internal protocols, the RBM companies operate prior authorization programs for high-end imaging scans. Statistics show they have been successful in reducing imaging utilization, but at the expense of complaints from clinicians and radiology practices upset by another layer of authority and procedures.
In the last three years, elite institutions such as Massachusetts General Hospital and Brigham and Women’s Hospital have developed “point of care” decision-support programs that use appropriateness algorithms to guide clinicians to better imaging exams at the time they are ordered. Systems developed at those facilities have been commercialized and are now entering the market.
A computerized approach has been tested in a five-facility, three-year pilot program in Minnesota and is now being offered to all facilities in the state, said Cally Vinz, an administrator in the pilot program who presented data from the pilot at Sunday’s scientific session. The pilot started with ACR criteria applied to electronic health record requests that did not require prior authorization. The number of high-tech scans did not increase in 2007 compared with an 8% increase in the prior year, Vince said. In addition, the diagnostic quality of the scans increased 10%, radiation dose was reduced, and increased efficiency shaved $84 million off of healthcare costs.
Time savings alone were substantial, Vince said. RBM approval took approximately 10 minutes. Computerized decision support took just 10 seconds.
The case for the RBM approach was made by Dr. Mark Hiatt, chief medical officer for HealthHelp, an RBM. He maintained that RBMs are a proven way to reduce excess utilization, something that will be important as more people are added to the insurance rolls under healthcare reform.
Using charts and graphs, Hiatt argued that high-tech imaging utilization flat-lined and then turned negative in both commercial and Medicare lines as a result of RBM controls. In the case of the five million patients covered by one of HealthHelp’s customers, utilization management yielded $90 million in savings over the course of five years.
“Getting the test right the first time is good medicine and saves money in the end,” Hiatt said.
In the question and answer session, Dr. David Levin, a medical director of HealthHelp and a longtime critic of self-referral, said utilization growth of high-tech procedures started to decline in 2005 and that Minnesota may have benefited from RBM controls even before their pilot started.
Vince agreed that the RBMs had an effect, but countered that computerized decision support offers a more patient- and clinician-friendly approach to utilization management.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.